Suppr超能文献

相似文献

1
Cure models as a useful statistical tool for analyzing survival.
Clin Cancer Res. 2012 Jul 15;18(14):3731-6. doi: 10.1158/1078-0432.CCR-11-2859. Epub 2012 Jun 6.
2
Analysis of survival data with cure fraction and variable selection: A pseudo-observations approach.
Stat Methods Med Res. 2022 Nov;31(11):2037-2053. doi: 10.1177/09622802221108579. Epub 2022 Jun 27.
3
Long-term outcomes after autologous stem cell transplantation for multiple myeloma.
Blood Adv. 2020 Jan 28;4(2):422-431. doi: 10.1182/bloodadvances.2019000524.
5
Estimating and modeling the cure fraction in population-based cancer survival analysis.
Biostatistics. 2007 Jul;8(3):576-94. doi: 10.1093/biostatistics/kxl030. Epub 2006 Oct 4.
6
A Bayesian long-term survival model parametrized in the cured fraction.
Biom J. 2009 Jun;51(3):443-55. doi: 10.1002/bimj.200800199.
7
A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
Pharm Stat. 2017 Jan;16(1):87-94. doi: 10.1002/pst.1790. Epub 2016 Nov 8.
10
A nonparametric mixture model for cure rate estimation.
Biometrics. 2000 Mar;56(1):237-43. doi: 10.1111/j.0006-341x.2000.00237.x.

引用本文的文献

1
4
A renewal-equation approach to estimating and infectious disease case counts in the presence of reporting delays.
Philos Trans A Math Phys Eng Sci. 2025 Mar 13;383(2292):20240357. doi: 10.1098/rsta.2024.0357.
7
Cure models, survival probabilities, and solid organ transplantation for patients with colorectal cancer.
Am J Transplant. 2025 Mar;25(3):545-555. doi: 10.1016/j.ajt.2024.08.018. Epub 2024 Sep 5.
8
Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in China.
Lancet Reg Health West Pac. 2024 Jul 19;49:101147. doi: 10.1016/j.lanwpc.2024.101147. eCollection 2024 Aug.
9
: An End-to-End Pipeline for Implementing Mixture Cure Models With an Application to Liposarcoma Data.
JCO Clin Cancer Inform. 2024 Aug;8:e2300234. doi: 10.1200/CCI.23.00234.

本文引用的文献

1
Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models.
J Am Stat Assoc. 2003 Dec 1;98(464):1063-1078. doi: 10.1198/01622145030000001007.
2
Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.
Cancer Treat Rev. 2010 May;36 Suppl 2:S18-23. doi: 10.1016/S0305-7372(10)70008-6.
3
A Semiparametric Regression Cure Model for Interval-Censored Data.
J Am Stat Assoc. 2009 Dec 1;104(487):1168-1178. doi: 10.1198/jasa.2009.tm07494.
6
Acute promyelocytic leukemia: from highly fatal to highly curable.
Blood. 2008 Mar 1;111(5):2505-15. doi: 10.1182/blood-2007-07-102798.
7
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
Br J Haematol. 2007 Jul;138(2):176-85. doi: 10.1111/j.1365-2141.2007.06639.x.
8
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
Br J Haematol. 2006 Oct;135(2):158-64. doi: 10.1111/j.1365-2141.2006.06271.x. Epub 2006 Aug 25.
9
Thalidomide and hematopoietic-cell transplantation for multiple myeloma.
N Engl J Med. 2006 Mar 9;354(10):1021-30. doi: 10.1056/NEJMoa053583.
10
A general class of Bayesian survival models with zero and nonzero cure fractions.
Biometrics. 2005 Jun;61(2):403-12. doi: 10.1111/j.1541-0420.2005.00329.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验